IMA Group acquires research site in Texas

By The Science Advisory Board staff writers

October 13, 2021 -- The IMA Group has acquired Diagnostics Research Group (DXRG), a clinical research site in San Antonio, TX.

The acquisition strengthens and broadens IMA's Clinical Research Division, a physician-founded network of integrated clinical research sites specializing in phase II-IV hybrid and fully decentralized trials in multiple therapeutic areas.

DXRG will continue to operate under its existing name. The financial terms of the deal were not disclosed.

NIIMBL spends $4.6M to fund biopharmaceutical projects
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is spending $4.6 million to fund 10 new biopharmaceutical manufacturing...

Copyright © 2021

Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter